Evidence map›Paper›PMID 41757944›Full record

ArticleThe Journal of infectious diseases2026

Comparison of CD4 T-Cell Response in Plasmodium falciparum and vivax Malaria.

Mayimuna Nalubega, Megan S F Soon, Dean Andrew, Amaya Ortega-Pajares, Jessica Canning, Nicholas Dooley, Jessica R Loughland, Christian Engwerda, Enny Kenangalem, Ric N Price and 4 more

Abstract readComparative Study
In one paragraph

Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mayimuna NalubegaBurnet Institute, Melbourne, Australia.ORCID 0000-0001-9152-5520
Megan S F SoonBurnet Institute, Melbourne, Australia.
Dean AndrewQIMR Berghofer Medical Research Institute, Herston, Australia.ORCID 0000-0001-6528-5439
Amaya Ortega-PajaresBurnet Institute, Melbourne, Australia.
Jessica CanningBurnet Institute, Melbourne, Australia.ORCID 0009-0003-3474-362X
Nicholas DooleyBurnet Institute, Melbourne, Australia.ORCID 0000-0002-9692-5627
Jessica R LoughlandBurnet Institute, Melbourne, Australia.
Christian EngwerdaQIMR Berghofer Medical Research Institute, Herston, Australia.
Enny KenangalemTimika Malaria Research Program, Papuan Health and Community Development Foundation, Timika, Indonesia.ORCID 0000-0002-0481-7435
Ric N PriceMenzies School of Health Research, Global and Tropical Health Division, Darwin, Australia.ORCID 0000-0003-2000-2874
Gabriela MinigoMenzies School of Health Research, Global and Tropical Health Division, Darwin, Australia.ORCID 0000-0001-5158-7700
Nicholas M AnsteyMenzies School of Health Research, Global and Tropical Health Division, Darwin, Australia.
Damian A OyongBurnet Institute, Melbourne, Australia.ORCID 0000-0003-3169-9849
Michelle J BoyleBurnet Institute, Melbourne, Australia.ORCID 0000-0002-0268-232X

Funding

Burnet InstituteChannel 7 Children's Research FoundationCharles Darwin UniversityCSL Centenary FellowshipIndependent Research Infrastructure Support SchemeMenzies School of Health ResearchNational Health and Medical Research Council of Australia 1125656National Health and Medical Research Council of Australia 1141632Senior Principal Research 1135820Snow Medical Foundation 2022/SF167Victorian State Government Operational Infrastructure Support
6 · The paper itself

Abstract

backgroundPlasmodium falciparum and vivax are parasites responsible for most malaria cases globally. In areas where these species coexist, individuals gain protection from P vivax more rapidly, and important biological differences between species may affect immune responses. CD4 T cells are key drivers of immunity to malaria as effector and helper cells, with T follicular helper cells having key roles in antibody development. Comparative studies on CD4 T cell responses between these species are limited.

methodsWe assessed CD4 T cells in adults with either P falciparum or P vivax malaria. Activation and proliferation of CD4 T cells were measured ex vivo, and functional capacity was determined by intracellular cytokine staining via flow cytometry.

resultsThe phenotype, activation, and proliferation of CD4 T cell subsets were largely comparable between species. However, within the peripheral T follicular helper (pTfh) cell compartment, there was some evidence for species-dependent activation, with relatively increased pTfh1 cells in P falciparum infection. Additionally, in P falciparum, increased IL-10 production was detected, including within IL-21-producing CD4 T cells.

conclusionsWhile activation and function of CD4 T cells in malaria are largely comparable, some species-dependent responses are detected within the pTfh-cell compartment that may affect antibody development.

Indexed as

CD4-Positive T-LymphocytesMalaria, FalciparumMalaria, VivaxPlasmodium falciparumPlasmodium vivaxAdultCell ProliferationCytokinesFemaleFlow CytometryHumansLymphocyte ActivationMaleMiddle AgedYoung AdultCytokinesCD4falciparummalariaT follicular helper cellsvivax

Identifiers

PMID41757944
PMCPMC13127770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.